comparemela.com

Latest Breaking News On - Hematology association - Page 15 : comparemela.com

Maintenance Darzalex Regimen Promising in Post-Transplant Myeloma

Maintenance Darzalex, with or without Pomalyst was safe and efficacious in treating patients with relapsed myeloma who underwent salvage autologous hematopoietic stem cell transplant.

United statesOren pasvolskyEuropean hematology association congressDepartment of stem cell transplantation cellular therapyUniversity of texas md anderson cancer centerHematology associationStem cell transplantationCellular therapyCancer center

BeiGene Highlights Promising Data from Blood Cancer Portfolio and Pipeline at the European Hematology Association Hybrid Congress

New follow-up results from Phase 3 SEQUOIA trial and post hoc safety analyses for BRUKINSA (zanubrutinib) reinforce potential across various B-cell malignancies Early results for BTK-targeted CDAC (BGB-16673)

United kingdomUnited statesMecklenburg vorpommernSouth koreaGreat britainKevin mannixStefan klotterMaryline ivaLai wangEuropean unionEuropean medicines agencyEuropean hematology associationExchange commissionAmerican society of clinical oncology annual meetingHematology associationGlobal head

Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas at European Hematology Association (EHA) Annual Meeting 2023

Results from phase 1/2 EPCORE NHL-2 trial investigating epcoritamab in combination with rituximab-lenalidomide (R2) showed a 98 percent overall response rate (ORR), 87 percent complete metabolic

United statesLhospitalet de llobregatComunidad autonoma de catalunaNew jerseyAndrew carlsenJudith klimovskyInstitut catalStefan klotterAnna suredaHematol hemoterDavid freundelAbbvie biotechnology ltdEuropean unionFollicular lymphoma international prognostic indexEuropean medicines agencyLymphoma research foundation

Gilteritinib as Maintenance Therapy Demonstrated Benefit in Subgroups of FLT3-ITD Acute Myeloid Leukemia Patients

/PRNewswire/ Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and the Blood and Marrow Transplant Clinical Trials Network (BMT.

United statesGreen bayMedical college of wisconsinMarym horowitzAhsan arozullahNaoki okamuraHead of oncology developmentMarrow transplant clinical trials networkMarrow transplant researchCollege of wisconsin withNational cancer institutePrnewswire astellas pharma incNational heartInternational bloodAmerican cancer societyAstellas pharma us inc

Novartis : unveils results from global patient and physician survey disrupting the notion that CML is a solved disease

Survey of Unmet Needs in chronic myeloid leukemia data signal need for amplified patient voice during treatment discussions that balance quality of life , efficacy, and. | June 9, 2023

South koreaUnited statesUnited kingdomParag mahantiMichael meoElisa machadoSloan simpsonNicole zinsli sommSatoshi sugimotoMary carmichaelSamir shahJulie masowIsabella zinckFabian langMarlena abdinoorRichard jarvis

vimarsana © 2020. All Rights Reserved.